Boston Scientific Rises After Earnings Beat Estimates
This article is for subscribers only.
Boston Scientific Corp., the second-biggest maker of heart devices, rose to its highest level in three months after its earnings beat analysts’ estimates.
The Natick, Massachusetts-based company increased 33 cents, or 5.5 percent, to $6.30 at 4 p.m. in New York Stock Exchange composite trading. The shares have declined 30 percent this year.